Case Study: USFDA approval of GSK’s Trelegy Ellipta – Triple Drug for COPD
Posted on20 Sep 2017
Comments0
GSK has won US approval for its triple-therapy inhaler for chronic obstructive pulmonary disease. Brand Name: Trelegy Ellipta Type: Triple Drug Combination... Read More
Case Study: Regeneron, Sanofi’s Dupilumab Development to approval
The U.S. Food and Drug Administration on Tuesday approved Regeneron Pharmaceuticals Inc and Sanofi SA’s drug for moderate-to-severe atopic dermatitis. Bio-molecule: Dupilumab... Read More
USFDA new drug approval: Xermelo for carcinoid syndrome diarrhea
Posted on03 Mar 2017
Tags2017 USFDA New Drug Apporval, Fast Track designation, orphan drug designation, priority review, Xermelo
Comments0
The U.S. Food and Drug Administration today approved Xermelo (telotristat ethyl) tablets in combination with somatostatin analog (SSA) therapy for the treatment... Read More
2017 USFDA New Drug Apporval: Emflaza tablets to treat Duchenne muscular dystrophy
The US Food and Drug Administration has approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older... Read More